The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin

British Journal of Dermatology

Volumn 168, Issue 2, 2013, Pages 339-345

  Kjellerup, R B ^a   Johansen, C ^a   Kragballe, K ^a   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; HU ANTIGEN; HU ANTIGEN R; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUNCH BIOPSY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CYTOKINES; DERMATITIS, ATOPIC; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; HUMANS; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PSORIASIS; RNA, MESSENGER;

EID: 84873167505     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12020     Document Type: Article

References (42)

1. Johansen C, Kragballe K, Westergaard M, et al. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 2005; 152: 37-42.
2. Johansen C, Vinter H, Soegaard-Madsen L, et al. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFalpha therapy. Br J Dermatol 2010; 163: 1194-204.
3. Kyriakis JM, Avruch J,. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-69.
4. Takahashi H, Ibe M, Nakamura S, et al. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci 2002; 30: 94-9.
5. Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol 2007; 83: 413-18.
6. Jeffrey KL, Camps M, Rommel C, et al. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007; 6: 391-403.
7. Funding AT, Johansen C, Kragballe K, et al. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J Invest Dermatol 2006; 126: 1784-91.
8. Funding AT, Johansen C, Kragballe K, et al. Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J Invest Dermatol 2007; 127: 2012-19.
9. Lang R, Hammer M, Mages J,. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006; 177: 7497-504.
10. Keyse SM, Emslie EA,. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992; 359: 644-7.
11. Abraham SM, Clark AR,. Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 2006; 34: 1018-23.
12. Boutros T, Chevet E, Metrakos P,. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 2008; 60: 261-310.
13. Salojin KV, Owusu IB, Millerchip KA, et al. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 2006; 176: 1899-907.
14. Dorfman K, Carrasco D, Gruda M, et al. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 1996; 13: 925-31.
15. Liu Y, Shepherd EG, Nelin LD,. MAPK phosphatases-regulating the immune response. Nat Rev Immunol 2007; 7: 202-12.
16. Korhonen R, Turpeinen T, Taimi V, et al. Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase. Mol Immunol 2011; 48: 2059-68.
17. Kuwano Y, Gorospe M,. Protecting the stress response, guarding the MKP-1 mRNA. Cell Cycle 2008; 7: 2640-2.
18. Eberhardt W, Doller A, Akool el-S, et al. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 2007; 114: 56-73.
19. Barreau C, Paillard L, Osborne HB,. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005; 33: 7138-50.
20. Kuwano Y, Kim HH, Abdelmohsen K, et al. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol 2008; 28: 4562-75.
21. Lin NY, Lin CT, Chang CJ,. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 2008; 365: 69-74.
22. Kjellerup RB, Kragballe K, Iversen L, et al. Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. Exp Dermatol 2008; 17: 498-504.
23. Gesser B, Johansen C, Rasmussen MK, et al. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. J Invest Dermatol 2007; 127: 2129-37.
24. Soegaard-Madsen L, Johansen C, Iversen L, et al. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br J Dermatol 2010; 162: 1216-23.
25. Kjellerup RB, Iversen L, Kragballe K, Johansen C,. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin. Br J Dermatol 2009; 161: 1059-66.
26. Ananieva O, Darragh J, Johansen C, et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 2008; 9: 1028-36.
27. Kim C, Sano Y, Todorova K, et al. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol 2008; 9: 1019-27.
28. Arthur JS, Fong AL, Dwyer JM, et al. Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins. J Neurosci 2004; 24: 4324-32.
29. Perera GK, Di Meglio P, Nestle FO,. Psoriasis. Annu Rev Pathol 2012; 7: 385-422.
30. Toh ML, Yang Y, Leech M, et al. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids. Arthritis Rheum 2004; 50: 3118-28.
31. Guo YL, Baysal K, Kang B, et al. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998; 273: 4027-34.
32. Lasa M, Abraham SM, Boucheron C, et al. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002; 22: 7802-11.
33. Guo YL, Kang B, Williamson JR,. Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998; 273: 10362-6.
34. Jang BC, Lim KJ, Suh MH, et al. Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells. FEMS Immunol Med Microbiol 2007; 51: 171-84.
35. Shibata M, Katsuyama M, Onodera T, et al. Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines. J Invest Dermatol 2009; 129: 375-82.
36. Johansen C, Funding AT, Otkjaer K, et al. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 2006; 176: 1431-8.
37. Davies SP, Reddy H, Caivano M, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
38. Staples CJ, Owens DM, Maier JV, et al. Cross-talk between the p38{alpha} and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation. J Biol Chem 2010; 285: 25928-40.
39. Shipp LE, Lee JV, Yu CY, et al. Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PLoS ONE 2010; 5: e13754.
40. Xu Q, Konta T, Furusu A, et al. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem 2002; 277: 41693-700.
41. Lu TC, Wang Z, Feng X, et al. Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes. Mol Cell Biol 2008; 28: 5785-94.
42. Menter A, Griffiths CE,. Current and future management of psoriasis. Lancet 2007; 370: 272-84.